IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...
A nurse, foster mom and the primary provider for a family of eight, Shelly Sepulveda has devoted her life to taking care of ...
In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...
A new pathway to fast track patients from the Preston area with suspected ovarian cancer is being implemented at the Royal ...
IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...
Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...
Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.
Initial plans target European clinical trials while providing standard testing to clinicians for individual patientsThere are an estimated ...
A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...
There are other ways to evaluate ovarian cancer patients beyond radiology ... remains responsible for the patient’s diagnosis and treatment." Epstein noted that AI should only be used as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback